Factor II (Prothrombin) Mutation

Factor II mutation, also known as prothrombin gene mutation or prothrombin G20210A mutation. Prothrombin is a precursor of thrombin, a protein that plays a role in the blood clotting process (also referred to as blood coagulation factor II). The Prothrombin G20210A mutation occurs in a specific region of the prothrombin gene and leads to an increased production of prothrombin compared to normal levels.

This mutation can enhance the blood clotting process due to alterations in the structure of prothrombin. Individuals carrying the Prothrombin G20210A mutation might have higher levels of prothrombin than usual, resulting in a faster blood clotting tendency and an increased risk of thrombosis.

Individuals with Factor II mutation may face an elevated risk of venous thrombosis, such as deep vein thrombosis (DVT). However, not everyone carrying this mutation will necessarily experience thrombosis. Nevertheless, considering that this mutation escalates the risk of thrombosis, appropriate measures should be taken based on the health condition and risk factors of these individuals. This test can be used to evaluate the risk of blood clotting and determine suitable treatment strategies.

What is the Factor II (Prothrombin) Mutation Test?

The Factor II (Prothrombin) mutation test is a medical examination conducted to detect a specific mutation in an individual's prothrombin gene. This test aims to identify a specific mutation called G20210A in prothrombin, a protein involved in the blood clotting process, which might lead to an increased production of prothrombin. The test is performed to determine the presence of this particular mutation in an individual's blood and may help ascertain whether this mutation increases the risk of thrombosis.

When is the Factor II (Prothrombin) Mutation Test Requested?

1. History of Thrombosis:

Individuals who have previously experienced deep vein thrombosis (DVT) or pulmonary embolism (PE), especially at a young age or those with a history of recurrent clots, may be requested to undergo this test.

2. Family History of Coagulation Disorders:

Individuals with a family history of coagulation disorders, especially those with a history of Factor II mutation, may undergo this test.

3. Recurrent Pregnancy Losses:

Women experiencing recurrent miscarriages or encountering thrombosis during pregnancy might be recommended to take this test.

4. Pregnant Women:

Pregnant women at a higher risk of blood clotting, especially with a family history of coagulation disorders or a previous history of thrombosis, may undergo the Factor II mutation test.

5. High-Risk Blood Clotting Conditions:

Particularly in conditions involving a high risk of blood clotting, such as post-surgery or prolonged bed rest, this test may be requested to assess the risk of clotting.

These circumstances are evaluated by doctors based on the individual's history, symptoms, and other factors affecting the risk of clotting, leading to the request for the Factor II mutation test. This test can aid in determining an individual's risk of clotting and contribute to the identification of appropriate treatment strategies.